Bachxen Pharmaceuticals Private Limited, a active private limited company, was established on 12 December 2018 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2018PTC318191. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mayuresh Suresh Nirmal (Director), Jessy Penattinmootil Mathai (Director). Past directors included Amit Narendra Desai, Deep Yatin Desai. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 202, Vrindavan Chs Sector 20 Cbd Belapur, Navi Mumbai, Maharashtra, 400614.
U74999MH2018PTC318191
318191
12 December 2018
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bachxen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayuresh Suresh Nirmal | Director | 03 Aug 2024 | Current |
| Jessy Penattinmootil Mathai | Director | 03 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2024 | Past |
| Pramod Abcsdd | Director | 05 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bachxen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 90785.96% increase. The company also saw a substantial improvement in profitability, with a 210.27% increase in profit. The company's net worth Soared by an impressive increase of 114.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Bachxen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bachxen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bachxen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bachxen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bachxen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Mayuresh Suresh Nirmal was appointed as a Director was appointed as a Director on 03 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
Jessy Penattinmootil Mathai was appointed as a Director was appointed as a Director on 03 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Bachxen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Bachxen Pharmaceuticals Private Limited was registered on 12 Dec 2018 with Roc Mumbai & aged 6 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Bachxen Pharmaceuticals Private Limited is U74999MH2018PTC318191.
Bachxen Pharmaceuticals Private Limited is headquartered at 202, Vrindavan Chs Sector 20 Cbd Belapur, Navi Mumbai, Maharashtra, 400614.
Bachxen Pharmaceuticals Private Limited was incorporated on 12 December 2018.
The current directors of Bachxen Pharmaceuticals Private Limited are
The primary industry of Bachxen Pharmaceuticals Private Limited is Pharma.
Bachxen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bachxen Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX